Guest Profile

Dr. Mike Yeadon

Dr. Mike Yeadon
Dr. Mike Yeadon

Scan QR code for the link to this page.

Dr. Michael Yeadon is an Allergy & Respiratory Therapeutic Area expert with 23 years in the pharmaceutical industry. and was VP and Chief Scientific Officer (Allergy & Respiratory Research) with Pfizer. He trained as a biochemist and pharmacologist, obtaining his PhD from the University of Surrey (UK) in 1988. Dr. Yeadon has published over 40 original research articles.

Dr. Michael Yeadon is an Allergy & Respiratory Therapeutic Area expert in the pharmaceutical industry. He trained as a biochemist and pharmacologist, obtaining his PhD from the University of Surrey (UK) in 1988.


Dr. Yeadon then worked at the Wellcome Research Labs with Salvador Moncada with a research focus on airway hyper-responsiveness and effects of pollutants including ozone and working in drug discovery of 5-LO, COX, PAF, NO and lung inflammation. With colleagues, he was the first to detect exhaled NO in animals and later to induce NOS in lung via allergic triggers.


As Pfizer's former Vice President and Chief Scientist for Allergy & Respiratory, he spent 32 years in the industry leading new medicines research and retired from the pharmaceutical giant with “the most senior research position” in his field.


Joining Pfizer in 1995, he was responsible for the growth and portfolio delivery of the Allergy & Respiratory pipeline within the company. He was responsible for target selection and the progress into humans of new molecules, leading teams of up to 200 staff across all disciplines and won an Achievement Award for productivity in 2008.


Under his leadership the research unit invented oral and inhaled NCEs which delivered multiple positive clinical proofs of concept in asthma, allergic rhinitis and COPD. He led productive collaborations such as with Rigel Pharmaceuticals (SYK inhibitors) and was involved in the licensing of Spiriva and acquisition of the Meridica (inhaler device) company.


Dr. Yeadon has published over 40 original research articles and now consults and partners with a number of biotechnology companies. Before working with Apellis, Dr. Yeadon was VP and Chief Scientific Officer (Allergy & Respiratory Research) with Pfizer.


Source: https://alethonews.com/2020/11/22/dr-michael-yeadon-unlocked/ 

Newspapers

Featured Articles

Guest Videos

Thumbnail
Title
Description
Category
Platform

Guest Podcasts

Thumbnail
Title
Description
Category